Our Products
Mahana is creating premium terpene and cannabinoid-based therapeutic products able to treat and support the health of patients suffering debilitating migraine headache.
Research
Mahana is a science-led company with ongoing research programmes targeted at developing next-generation cannabis based migraine medicines
Developing a deeper understanding of the interaction of phytocannabinoids with the endocannabinoid system will lead to new areas of cannabinoid migraine therapeutics enabling improved quality of life, and better outcomes for migraine sufferers worldwide.
We take pride in the time and effort we put into developing the ingredients, formulations and technical specifications of our future product ranges. All Mahana medicinal cannabis products will be produced under GMP and will offer unique combinations and levels of cannabinoids designed to address the various stages of the migraine headache process, from day to day headache prophylactic management to acute rescue and recovery.
Quality Assurance
Mahana will cultivate high quality cannabis flower for our R&D programmes.
Our high-tech medicinal cannabis grow facility will produce some of New Zealand’s finest medical cannabis. Our medical-grade cannabis products will be grown in accordance with rigorous health and safety standards and produced under Good Manufacturing Practices, known as GMP. This ensures all Mahana products are consistent, safe and reliable. GMP is the world’s gold standard for medicinal products.
Research Programs
Through our research partner, University of Auckland, we are interested in supporting Post-Graduate students in the following areas
Chemical Engineering
Extraction + Isolation
Plant Biology
Crop Diversity + Resilience
